Product logo
  • Home
  • Sign Up
Product logo

Gland Pharma Ltd

News

Switch to
Share
    Home
    Sign Up

    Gland Pharma Ltd

    GLAND
    3,065.7033.80 (-1.09%)
    Investment Checklist
    BasicPro

    Intrinsic Value
    Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

    Current price is more than the intrinsic value

    ROE vs FD rates
    Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

    Stock has been generating better return on equity than bank FD

    Dividend Returns
    A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

    Insufficient Data

    Entry Point
    High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

    Good time to consider, as stock is not in overbought zone

    No Red Flags
    ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks

    Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

    Loading...
    Go pro! Unlock deeper insights
    Get your Zerodha accountOpen Now
    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    1.0 k

    News & Opinions

    1.0 k
    Articles & Videos
    News Thumbnail
    Latest

    Buy Gland Pharma: target of Rs 3770: Sharekhan

    16 hours ago•Moneycontrol

    News Thumbnail
    Latest

    Buy Gland Pharma; target of Rs 3700: Motilal Oswal

    17 hours ago•Moneycontrol

    News Thumbnail
    Latest

    Gland Pharma Q4 Review - Strong Growth Across Geographies To Drive Profitability: Axis Securities

    1 day ago•Bloomberg Quint

    News Thumbnail

    Gland Pharma Q4 Review - Robust Prospects Led By Efforts On Multiple Fronts: Motilal Oswal

    2 days ago•Bloomberg Quint

    News Thumbnail

    Stocks to Watch: HPCL, Ashok Leyland, Eros, Godrej Consumer, Gland Pharma

    2 days ago•Business Standard

    News Thumbnail

    Gland Pharma consolidated net profit rises 9.79% in the March 2022 quarter

    2 days ago•Business Standard

    News Thumbnail

    Gland Pharma launches generic cancer treatment drug in US

    2 weeks ago•Economic Times

    News Thumbnail

    Gland Pharma announces launch of Bortezomib for Injection in US market

    2 weeks ago•Business Standard

    News Thumbnail

    Gland Pharma stock falls over 3% after Nicomac Machinery sells stake

    4 weeks ago•Business Today

    News Thumbnail

    Bulk deals | Menu exits Barbeque Nation, Nicomac Machinery cuts stake in Gland Pharma

    1 month ago•Moneycontrol

    © Powered byTickertape.ViewGLANDon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019